Novavax announced COVID-19 vaccine booster data demonstrating four-fold Increase in neutralizing antibody
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
Lenzilumab treatment may provide enhanced likelihood of survival without ventilation in hospitalized black and African-American COVID-19 patients
On Aug. 4, 2021, Humanigen announced analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in…
Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
NEJM published positive phase 3 trial results for REGEN-COV to prevent SARS-CoV-2 infection
On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…
CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
FDA expanded authorized use of REGEN-COVﾙ (casirivimab and imdevimab)
On Jul. 30, 2021, Regeneron announced that the FDA had updated the Emergency Use Authorization (EUA) for the…
COVID-19 | FDA | Therapeutics
FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19
On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…
Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facility
On Jul. 29, 2021, Emergent BioSolutions announced that the FDA had begun allowing Emergent’s Bayview manufacturing facility to…
Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in preclinical study
On Jul. 28, 2021, GlaxoSmithKline and Vir Biotechnology announced they had signed a Joint Procurement Agreement with the…
COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding
On Jul. 27, 2021, the National Institutes of Health announced that the COVID-19 vaccine AZD1222, when delivered into…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Life Science History | Therapeutics | Vaccine
The COVID-19 Vaccine
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
American Medical Association announced support of COVID-19 vaccine mandates for health care workers
On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…
American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals
On Jul. 26, 2021, the American Nurses Association (ANA), representing the interests of the nationﾒs 4.2 million registered…
COVAX and World Bank accelerated COVID-19 vaccine access for developing countries
On Jul. 26, 2021, COVAX and the World Bank accelerated COVID-19 vaccine supply for developing countries through a…
Department of Veterans Affairs mandated COVID-19 vaccines among employees, including facilities staff
On Jul. 26, 2021, the Department of Veterans Affairs (VA) announced that it had mandated COVID-19 vaccines for…
Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 vacation Destinations
Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…
CHMP adopted positive opinion recommending authorization for use of the Moderna COVID-19 vaccine in adolescents in EU
On Jul. 23, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccine
On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government had purchased an additional 200 million…
Humanigenﾒs partner in South Korea received pproval to conduct phase 1 study of lenzilumab
On Jul. 21, 2021, Humanigen announced its development and commercialization partners for South Korea and the Philippines, Telcon…
Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
Sorrento announced dosing of COVID-19 patients in phase 2 clinical trial for COVIDROPS neutralizing antibody against SARS-CoV-2
On Jul. 21, 2021, Sorrento Therapeutics announced that COVID-19 patients had been dosed in its Phase 2 efficacy…
Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in Africa
On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…
Japan became first country to approve Ronapreve (casirivimab and imdevimab) for ttreatment of mild to moderate COVID-19
On Jul. 20, 2021, Roche announced that Japanﾒs Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreveﾙ(casirivimab…
Moderna partnered with Takeda and Government of Japan to aupply additional 50 million doses of COVID-19 vaccine and variant booster candidate
On Jul. 20, 2021, Moderna announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and…
Japan became first country to approve Regeneron antibody cocktail (casirivimab and imdevimab) for treatment of COVID-19
On Jul. 20, 2021, Regeneron announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) had approved Regeneron’s…